Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to $54.15.

  • CorMedix's Times Interest Earned rose 11648.34% to $54.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $106.62, marking a year-over-year increase of 10920.64%. This contributed to the annual value of -$614.1 for FY2024, which is 5698.08% up from last year.
  • According to the latest figures from Q3 2025, CorMedix's Times Interest Earned is $54.15, which was up 11648.34% from $2929.6 recorded in Q2 2025.
  • In the past 5 years, CorMedix's Times Interest Earned registered a high of $2929.6 during Q2 2025, and its lowest value of -$2333.9 during Q2 2024.
  • For the 5-year period, CorMedix's Times Interest Earned averaged around -$701.71, with its median value being -$1255.4 (2023).
  • Its Times Interest Earned has fluctuated over the past 5 years, first tumbled by 8800.26% in 2021, then soared by 22552.65% in 2025.
  • Over the past 5 years, CorMedix's Times Interest Earned (Quarter) stood at -$1446.6 in 2021, then soared by 33.91% to -$956.04 in 2022, then grew by 16.51% to -$798.24 in 2023, then surged by 261.94% to $1292.7 in 2024, then crashed by 95.81% to $54.15 in 2025.
  • Its last three reported values are $54.15 in Q3 2025, $2929.6 for Q2 2025, and $2011.1 during Q1 2025.